trending Market Intelligence /marketintelligence/en/news-insights/trending/aoshxwffhvorx7dlmuwkaw2 content esgSubNav
In This List

Arcus Biosciences closes $138M IPO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Arcus Biosciences closes $138M IPO

Arcus Biosciences Inc. closed its IPO of 8 million common shares priced at $15 apiece to raise $138 million in gross proceeds.

The underwriters fully exercised their overallotment option to buy an additional 1.2 million shares.

Citigroup, Goldman Sachs & Co. LLC and Leerink Partners acted as joint book-running managers for the offering.